Literature DB >> 11406094

A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2).

R W Robey1, Y Honjo, A van de Laar, K Miyake, J T Regis, T Litman, S E Bates.   

Abstract

The fluorescent compounds rhodamine 123, LysoTracker Green DMD-26, mitoxantrone, and BODIPY-prazosin were used with the antagonist fumitremorgin C (FTC) in order to develop functional assays for the half-transporter, MXR/BCRP/ABCP1. A measure of FTC-inhibitable efflux was generated for each compound in a series of MXR-overexpressing drug-selected cell lines and in ten unselected cell lines which were used to determine if the four fluorescent compounds were sensitive enough to detect the low MXR levels found in drug-sensitive cell lines. FTC-inhibitable efflux of mitoxantrone and prazosin was found in four of the ten cell lines, SF295, KM12, NCI-H460, and A549, and low but detectable levels of MXR mRNA were also observed by Northern analysis in these cells. FTC-inhibitable mitoxantrone and prazosin efflux in both selected and unselected cell lines was found to correlate well with MXR levels as determined by Northern blotting, r(2)=0.89 and r(2)=0.70 respectively. In contrast, rhodamine and LysoTracker were not able to reliably detect MXR. Cytotoxicity assays performed on two of the four unselected cell lines confirmed increased sensitivity to mitoxantrone in the presence of FTC. FTC was found to be a specific inhibitor of MXR, with half-maximal inhibition of MXR-associated ATPase activity at 1 microM FTC. Short term selections of the SF295, KM12, NCI-H460 and A549 cell lines in mitoxantrone resulted in a small but measurable increase in MXR by both Northern blot and functional assay. These studies show that flow cytometric measurement of FTC-inhibitable mitoxantrone or prazosin efflux is a sensitive and specific method for measuring the function of the MXR half-transporter in both selected and unselected cell lines.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11406094     DOI: 10.1016/s0005-2736(01)00308-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  73 in total

1.  Flavonoids from eight tropical plant species that inhibit the multidrug resistance transporter ABCG2.

Authors:  Muhammad Ali Versiani; Thushara Diyabalanage; Ranjala Ratnayake; Curtis J Henrich; Susan E Bates; James B McMahon; Kirk R Gustafson
Journal:  J Nat Prod       Date:  2011-01-28       Impact factor: 4.050

2.  A high-content assay strategy for the identification and profiling of ABCG2 modulators in live cells.

Authors:  Christophe Antczak; Boyoung Wee; Constantin Radu; Bhavneet Bhinder; Eric C Holland; Hakim Djaballah
Journal:  Assay Drug Dev Technol       Date:  2013-08-30       Impact factor: 1.738

3.  Ocular surface epithelia contain ABCG2-dependent side population cells exhibiting features associated with stem cells.

Authors:  Murat T Budak; Onder S Alpdogan; Mingyuan Zhou; Robert M Lavker; M A Murat Akinci; J Mario Wolosin
Journal:  J Cell Sci       Date:  2005-04-15       Impact factor: 5.285

4.  Identification of inhibitors of ABCG2 by a bioluminescence imaging-based high-throughput assay.

Authors:  Yimao Zhang; Youngjoo Byun; Yunzhao R Ren; Jun O Liu; John Laterra; Martin G Pomper
Journal:  Cancer Res       Date:  2009-06-30       Impact factor: 12.701

5.  Investigation of chalcones as selective inhibitors of the breast cancer resistance protein: critical role of methoxylation in both inhibition potency and cytotoxicity.

Authors:  Glaucio Valdameri; Charlotte Gauthier; Raphaël Terreux; Rémy Kachadourian; Brian J Day; Sheila M B Winnischofer; Maria E M Rocha; Véronique Frachet; Xavier Ronot; Attilio Di Pietro; Ahcène Boumendjel
Journal:  J Med Chem       Date:  2012-04-02       Impact factor: 7.446

Review 6.  ABCG transporters: structure, substrate specificities and physiological roles : a brief overview.

Authors:  Saroj Velamakanni; Shen L Wei; Tavan Janvilisri; Hendrik W van Veen
Journal:  J Bioenerg Biomembr       Date:  2007-12       Impact factor: 2.945

7.  Reduced expression of DNA topoisomerase I in SF295 human glioblastoma cells selected for resistance to homocamptothecin and diflomotecan.

Authors:  Zhiyong Liao; Robert W Robey; Josée Guirouilh-Barbat; Kenneth K W To; Orsolya Polgar; Susan E Bates; Yves Pommier
Journal:  Mol Pharmacol       Date:  2007-11-05       Impact factor: 4.436

8.  ARRY-334543 reverses multidrug resistance by antagonizing the activity of ATP-binding cassette subfamily G member 2.

Authors:  De-Shen Wang; Atish Patel; Hong-May Sim; Yun-Kai Zhang; Yi-Jun Wang; Rishil J Kathawala; Hui Zhang; Tanaji T Talele; Suresh V Ambudkar; Rui-Hua Xu; Zhe-Sheng Chen
Journal:  J Cell Biochem       Date:  2014-08       Impact factor: 4.429

9.  Combined effects of multiple flavonoids on breast cancer resistance protein (ABCG2)-mediated transport.

Authors:  Shuzhong Zhang; Xinning Yang; Marilyn E Morris
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

Review 10.  PharmGKB summary: very important pharmacogene information for ABCG2.

Authors:  Alison E Fohner; Deanna J Brackman; Kathleen M Giacomini; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2017-11       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.